Cleared Traditional

K041028 - CROWN DELTA HYDROPHILIC IMPRESSION MATE...

K041028 is the FDA 510(k) clearance for CROWN DELTA HYDROPHILIC IMPRESSION MATE... by Crown Delta Corp.. It is a Class 2 Dental device (product code ELW) cleared through the Traditional 510(k) pathway after a 23-day FDA review.

K041028 · Crown Delta Corp. · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2004
Decision
23d
Days
Class 2
Risk

K041028 is an FDA 510(k) clearance for the CROWN DELTA HYDROPHILIC IMPRESSION MATERIAL. Classified as Material, Impression (product code ELW), Class II - Special Controls.

Submitted by Crown Delta Corp. (Yorktown Heights, US). The FDA issued a Cleared decision on May 14, 2004 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3660 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Crown Delta Corp. devices

Submission Details

510(k) Number K041028 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 2004
Decision Date May 14, 2004
Days to Decision 23 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
104d faster than avg
Panel avg: 127d · This submission: 23d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code ELW Material, Impression
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.